AAAAAA
Results: 1-25/63
Authors:
MAERZ WJ
BASELGA J
REUTER VE
MELLADO B
MYERS ML
BOSL GJ
SPINELLA MJ
DMITROVSKY E
Citation: Wj. Maerz et al., FGF4 DISSOCIATES ANTI-TUMORIGENIC FROM DIFFERENTIATION SIGNALS OF RETINOIC ACID IN HUMAN EMBRYONAL CARCINOMAS, Oncogene, 17(6), 1998, pp. 761-767
Authors:
HOULDSWORTH J
XIAO H
MURTY VVVS
CHEN WY
RAY B
REUTER VE
BOSL GJ
CHAGANTI RSK
Citation: J. Houldsworth et al., HUMAN MALE GERM-CELL TUMOR RESISTANCE TO CISPLATIN IS LINKED TO TP53 GENE MUTATION, Oncogene, 16(18), 1998, pp. 2345-2349
Authors:
BOSL GJ
Citation: Gj. Bosl, GERM-CELL TUMORS - THERE IS STILL PLENTY TO LEARN, Journal of clinical oncology, 16(4), 1998, pp. 1244-1247
Authors:
BAJORIN DF
MAZUMDAR M
MEYERS M
MOTZER RJ
VLAMIS V
LIN P
BOSL GJ
Citation: Df. Bajorin et al., METASTATIC GERM-CELL TUMORS - MODELING FOR RESPONSE TO CHEMOTHERAPY, Journal of clinical oncology, 16(2), 1998, pp. 707-715
Authors:
BAJORIN DF
BOSL GJ
Citation: Df. Bajorin et Gj. Bosl, BLEOMYCIN IN NONSEMINOMATOUS GERM-CELL TUMORS - CURE RATE VERSUS MORBIDITY - REPLY, Journal of clinical oncology, 16(2), 1998, pp. 800-800
Authors:
MOTZER RJ
AMSTERDAM A
PRIETO V
SHEINFELD J
MURTY VVS
MAZUMDAR M
BOSL GJ
CHAGANTI RSK
REUTER VE
Citation: Rj. Motzer et al., TERATOMA WITH MALIGNANT TRANSFORMATION - DIVERSE MALIGNANT HISTOLOGIES ARISING IN MEN WITH GERM-CELL TUMORS, The Journal of urology, 159(1), 1998, pp. 133-138
Authors:
RAO PH
HOULDSWORTH J
PALANISAMY N
MURTY VVVS
REUTER VE
MOTZER RJ
BOSL GJ
CHAGANTI RSK
Citation: Ph. Rao et al., CHROMOSOMAL AMPLIFICATION IS ASSOCIATED WITH CISPLATIN RESISTANCE OF HUMAN MALE GERM-CELL TUMORS, Cancer research, 58(19), 1998, pp. 4260-4263
Authors:
BOSL GJ
Citation: Gj. Bosl, OPERATION ON THE THORACIC AORTA - REPLY, The Annals of thoracic surgery, 66(2), 1998, pp. 606-606
Authors:
HOULDSWORTH J
REUTER V
BOSL GJ
CHAGANTI RSK
Citation: J. Houldsworth et al., ABERRANT EXPRESSION OF CYCLIN D2 IS AN EARLY EVENT IN HUMAN MALE GERM-CELL TUMORIGENESIS, Cell growth & differentiation, 8(3), 1997, pp. 293-299
Authors:
MOTZER RJ
MAZUMDAR M
BAJORIN DF
BOSL GJ
LYN P
VLAMIS V
Citation: Rj. Motzer et al., HIGH-DOSE CARBOPLATIN, ETOPOSIDE, AND CYCLOPHOSPHAMIDE WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN FIRST-LINE THERAPY FOR PATIENTS WITH POOR-RISK GERM-CELL TUMORS, Journal of clinical oncology, 15(7), 1997, pp. 2546-2552
LONG-TERM FOLLOW-UP OF PATIENTS WITH GOOD-RISK GERM-CELL TUMORS TREATED WITH ETOPOSIDE AND CISPLATIN
Authors:
XIAO H
MAZUMDAR M
BAJORIN DF
SAROSDY M
VLAMIS V
SPICER J
FERRARA J
BOSL GJ
MOTZER RJ
Citation: H. Xiao et al., LONG-TERM FOLLOW-UP OF PATIENTS WITH GOOD-RISK GERM-CELL TUMORS TREATED WITH ETOPOSIDE AND CISPLATIN, Journal of clinical oncology, 15(7), 1997, pp. 2553-2558
Authors:
MCCAFFREY JA
MAZUMDAR M
BAJORIN DF
BOSL GJ
VLAMIS V
MOTZER RJ
Citation: Ja. Mccaffrey et al., IFOSFAMIDE-CONTAINING AND CISPLATIN-CONTAINING CHEMOTHERAPY AS FIRST-LINE SALVAGE THERAPY IN GERM-CELL TUMORS - RESPONSE AND SURVIVAL, Journal of clinical oncology, 15(7), 1997, pp. 2559-2563
Authors:
BAJORIN DF
BOSL GJ
Citation: Df. Bajorin et Gj. Bosl, BLEOMYCIN IN GERM-CELL TUMOR-THERAPY - NOT ALL REGIMENS ARE CREATED EQUAL, Journal of clinical oncology, 15(5), 1997, pp. 1717-1719
Authors:
MEAD GM
STENNING SP
COOK P
FOSSA SD
HORWICH A
KAYE SB
OLIVER RTD
DEMULDER PHM
DEWIT R
STOTER G
SYLVESTER RJ
BAJORIN DF
BOSL GJ
MAZUMDAR M
NICHOLS CR
AMATO R
PIZZOCARO G
DROZ JP
KRAMAR A
DAUGAARD G
CORTESFUNES H
PAZARES L
LEVI JA
COLLS BM
HARVEY VJ
COPPIN C
Citation: Gm. Mead et al., INTERNATIONAL GERM-CELL CONSENSUS CLASSIFICATION - A PROGNOSTIC FACTOR-ERASED STAGING SYSTEM FOR METASTATIC GERM-CELL CANCERS, Journal of clinical oncology, 15(2), 1997, pp. 594-603
Authors:
BOSL GJ
MOTZER RJ
Citation: Gj. Bosl et Rj. Motzer, TESTICULAR GERM-CELL CANCER, The New England journal of medicine, 337(4), 1997, pp. 242-253
Authors:
BOSL GJ
Citation: Gj. Bosl, TESTICULAR GERM-CELL CANCER (VOL 337, PG 242, 1997), The New England journal of medicine, 337(19), 1997, pp. 1403-1403
Authors:
HERR HW
SHEINFELD J
PUC HS
HEELAN R
BAJORIN DF
MENCEL P
BOSL GJ
MOTZER RJ
Citation: Hw. Herr et al., SURGERY FOR A POSTCHEMOTHERAPY RESIDUAL MASS IN SEMINOMA, The Journal of urology, 157(3), 1997, pp. 860-862
Authors:
AFIFI HY
BOSL GJ
BURT ME
Citation: Hy. Afifi et al., MEDIASTINAL GROWING TERATOMA SYNDROME, The Annals of thoracic surgery, 64(2), 1997, pp. 359-362
Authors:
ZELEFSKY MJ
KRAUS DH
PFISTER DG
RABEN A
SHAH JP
STRONG EW
SPIRO RH
BOSL GJ
HARRISON LB
Citation: Mj. Zelefsky et al., COMBINED CHEMOTHERAPY AND RADIOTHERAPY VERSUS SURGERY AND POSTOPERATIVE RADIOTHERAPY FOR ADVANCED HYPOPHARYNGEAL CANCER, Head & neck, 18(5), 1996, pp. 405-411
Authors:
MURTY VVVS
REUTER VE
BOSL GJ
CHAGANTI RSK
Citation: Vvvs. Murty et al., DELETION MAPPING IDENTIFIES LOSS OF HETEROZYGOSITY AT 5P15.1-15.2, 5Q11 AND 5Q34-35 IN HUMAN MALE GERM-CELL TUMORS, Oncogene, 12(12), 1996, pp. 2719-2723
Authors:
MURTY VVVS
RENAULT B
FALK CT
BOSL GJ
KUCHERLAPATI R
CHAGANTI RSK
Citation: Vvvs. Murty et al., PHYSICAL MAPPING OF A COMMONLY DELETED REGION, THE SITE OF A CANDIDATE TUMOR-SUPPRESSOR GENE, AT 12Q22 IN HUMAN MALE GERM-CELL TUMORS, Genomics, 35(3), 1996, pp. 562-570
Authors:
MOTZER RJ
MAZUMDAR M
BOSL GJ
BAJORIN DF
AMSTERDAM A
VLAMIS V
Citation: Rj. Motzer et al., HIGH-DOSE CARBOPLATIN, ETOPOSIDE, AND CYCLOPHOSPHAMIDE FOR PATIENTS WITH REFRACTORY GERM-CELL TUMORS - TREATMENT RESULTS AND PROGNOSTIC FACTORS FOR SURVIVAL AND TOXICITY, Journal of clinical oncology, 14(4), 1996, pp. 1098-1105
Authors:
PUC HS
HEELAN R
MAZUMDAR M
HERR H
SCHEINFELD J
VLAMIS V
BAJORIN DF
BOSL GJ
MENCEL P
MOTZER RJ
Citation: Hs. Puc et al., MANAGEMENT OF RESIDUAL MASS IN ADVANCED SEMINOMA - RESULTS AND RECOMMENDATIONS FROM THE MEMORIAL SLOAN-KETTERING CANCER CENTER, Journal of clinical oncology, 14(2), 1996, pp. 454-460
Authors:
STEYERBERG EW
KEIZER HJ
FOSSA SD
SLEIJFER DT
TONER GC
KOOPS HS
MULDERS PFA
MESSEMER JE
NEY K
DONOHUE JP
BAJORIN D
STOTER G
BOSL GJ
HABBEMA JDF
Citation: Ew. Steyerberg et al., PREDICTION OF RESIDUAL RETROPERITONEAL MASS HISTOLOGY AFTER CHEMOTHERAPY FOR METASTATIC NONSEMINOMATOUS GERM-CELL TUMOR - MULTIVARIATE-ANALYSIS OF INDIVIDUAL PATIENT DATA FROM 6 STUDY-GROUPS, Journal of clinical oncology, 13(5), 1995, pp. 1177-1187
Authors:
PFISTER DG
HARRISON LB
STRONG EW
SHAH JP
SPIRO RW
KRAUS DH
ARMSTRONG JG
ZELEFSKY MJ
FASS DE
WEISS MH
WANG RC
SCHANTZ SP
BOSL GJ
Citation: Dg. Pfister et al., ORGAN-FUNCTION PRESERVATION IN ADVANCED OROPHARYNX CANCER - RESULTS WITH INDUCTION CHEMOTHERAPY AND RADIATION, Journal of clinical oncology, 13(3), 1995, pp. 671-680